The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after President Donald Trump dramatically cut global aid.

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...

Tennessee Gov. Bill Lee said the state had applied for a federal grant funding for rural healthcare, hoping for a piece of ...

HIV, the human immunodeficiency virus that can cause AIDS if left untreated, is much less of a transmission risk today than it was 20 years ago, thanks to public awareness about prevention (and ...

Please provide your email address to receive an email when new articles are posted on . The United States needs 1,500 more HIV specialists to achieve important treatment benchmarks. The shortage of ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...

In a time when both health care costs and climate worries seem to dominate the headlines, a team of researchers from the University of Maine has shared a rare piece of good news — one that could lead ...